OSG — Octave Specialty Group, Inc.

Summary of OSG Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Net Loss: $30 million ($0.84 per share) in Q4 2025, compared to a net loss of $22 million ($0.56 per share) in Q4 2024.
• Adjusted EBITDA: Increased to $1.4 million from $0.5 million year-over-year, driven by growth in the Insurance Distribution segment and reduced corporate expenses.
• Total Revenues: Up 5% to just under $47 million, affected by lower profit commissions and FX gains.
• Insurance Distribution Segment: Grew premium production by 9% and commission revenue by 13%, with organic revenue growth of over 8%.
• Everspan Performance: Gross premiums written increased by 34%, with a loss ratio of 62.9%, improved from 66.8% in the previous year.

2. Strategic Updates and Business Highlights

• Transformation Milestone: Q4 2025 marked the first full quarter as a stand-alone specialty insurance platform.
• Acquisition of ArmadaCare: Acquired in Q4, enhancing product diversification and expected to contribute significantly to A&H revenue.
• Launch of 1889 Specialty: A new MGA focused on management liability and professional lines for SMEs.
• Technology Integration: Ongoing efforts to unify operating infrastructure and implement AI-driven tools to improve risk selection and operational efficiency.

3. Forward Guidance and Outlook

• 2026 Expectations:
  • Insurance Distribution Segment: Anticipated organic revenue growth of at least 20%.
  • Specialty Insurance Segment: Expected gross written premiums of around $410 million and adjusted EBITDA of approximately $7.5 million.
  • Corporate Adjusted Expenses: Projected to be below $30 million.
  • Consolidated Adjusted Net Income: Expected to be around $0.50 per share.

4. Bad News, Challenges, or Points of Concern

• Increased Losses: The Q4 net loss was attributed to acquisition costs, exit from the financial guarantee business, and an impairment of a legacy investment.
• Everspan's Performance: Although repositioned for growth, Everspan's adjusted EBITDA declined from the previous year, indicating ongoing challenges.
• High G&A Ratio: At 11.7%, higher than desired, although expected to decrease as the company scales.
• Market Dynamics: Facing a challenging market environment with some segments experiencing rate reductions, particularly in non-cat property.

5. Notable Q&A Insights

• Pipeline for New MGAs: Claude LeBlanc indicated a focus on 2-4 new MGAs per year, primarily in the U.S. market, as they aim for growth.
• Cash Flow and NCI Buy-in: Expected to be less than $50 million for 2026, with funding from cash and marginal additional borrowing.
• Seasonality of Earnings: Earnings are expected to be weighted towards the first and fourth quarters, particularly for A&H businesses.
• Pricing Environment: Mixed trends with non-cat property seeing reductions of 5-10%, while casualty lines are experiencing stable rates or increases, particularly in excess casualty lines. A&H is seeing strong organic growth with pricing increases around 10-12%.

This summary encapsulates the key points discussed during the earnings call, providing a balanced view of Octave Specialty Group's performance and outlook.